| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mycobacterium bovis | 3 | 2018 | 125 | 1.88 | Why? |
| Myocytes, Smooth Muscle | 4 | 2018 | 127 | 1.48 | Why? |
| Asthma | 23 | 2021 | 4383 | 1.27 | Why? |
| Pulmonary Disease, Chronic Obstructive | 14 | 2020 | 3832 | 1.15 | Why? |
| Granulomatous Disease, Chronic | 3 | 2019 | 60 | 1.10 | Why? |
| Airway Remodeling | 4 | 2019 | 111 | 1.05 | Why? |
| Exosomes | 3 | 2019 | 567 | 1.00 | Why? |
| Macrophages | 4 | 2018 | 2784 | 0.96 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2021 | 229 | 0.93 | Why? |
| Mycobacterium Infections | 2 | 2018 | 72 | 0.88 | Why? |
| Sputum | 12 | 2021 | 1720 | 0.85 | Why? |
| Androstadienes | 2 | 2017 | 27 | 0.79 | Why? |
| MicroRNAs | 5 | 2019 | 1787 | 0.75 | Why? |
| Benzyl Alcohols | 1 | 2017 | 22 | 0.72 | Why? |
| Chlorobenzenes | 1 | 2017 | 35 | 0.71 | Why? |
| Bronchi | 9 | 2019 | 1048 | 0.69 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.66 | Why? |
| Adrenergic beta-2 Receptor Agonists | 2 | 2017 | 142 | 0.65 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.65 | Why? |
| Sarcoidosis, Pulmonary | 1 | 2017 | 91 | 0.63 | Why? |
| Tumor Microenvironment | 1 | 2018 | 264 | 0.62 | Why? |
| Pleura | 1 | 2017 | 178 | 0.62 | Why? |
| DNA Methylation | 2 | 2018 | 688 | 0.61 | Why? |
| Nitric Oxide | 4 | 2020 | 769 | 0.59 | Why? |
| Tumor Necrosis Factor-alpha | 3 | 2021 | 2483 | 0.59 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.59 | Why? |
| Budesonide | 1 | 2017 | 192 | 0.59 | Why? |
| Phagocytosis | 1 | 2017 | 409 | 0.57 | Why? |
| Mycoses | 2 | 2019 | 589 | 0.57 | Why? |
| Ozone | 3 | 2019 | 757 | 0.56 | Why? |
| Erythrocytes | 1 | 2020 | 617 | 0.56 | Why? |
| Transcription, Genetic | 2 | 2019 | 1326 | 0.54 | Why? |
| Smoke | 2 | 2019 | 349 | 0.53 | Why? |
| Emphysema | 3 | 2019 | 52 | 0.53 | Why? |
| Respiratory Tract Diseases | 2 | 2019 | 1061 | 0.53 | Why? |
| Gene Expression Profiling | 7 | 2019 | 3788 | 0.53 | Why? |
| Bronchodilator Agents | 2 | 2017 | 444 | 0.51 | Why? |
| Carbon Dioxide | 1 | 2020 | 917 | 0.51 | Why? |
| Ventilator Weaning | 1 | 2017 | 536 | 0.48 | Why? |
| Amides | 2 | 2021 | 1864 | 0.46 | Why? |
| Transcriptome | 5 | 2019 | 3466 | 0.45 | Why? |
| Cytokines | 10 | 2021 | 15010 | 0.42 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.42 | Why? |
| Disease Susceptibility | 3 | 2019 | 4002 | 0.42 | Why? |
| Pyrazines | 1 | 2021 | 1783 | 0.39 | Why? |
| Gene Expression Regulation | 5 | 2019 | 4020 | 0.38 | Why? |
| Alveolar Epithelial Cells | 1 | 2017 | 1445 | 0.37 | Why? |
| Environmental Exposure | 1 | 2019 | 1558 | 0.36 | Why? |
| Mitochondria | 4 | 2019 | 857 | 0.36 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.34 | Why? |
| Inflammation Mediators | 3 | 2017 | 2654 | 0.34 | Why? |
| Eosinophils | 7 | 2019 | 848 | 0.33 | Why? |
| Respiratory System | 3 | 2019 | 3213 | 0.33 | Why? |
| Th2 Cells | 4 | 2018 | 680 | 0.32 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.32 | Why? |
| Adrenergic beta-Agonists | 2 | 2005 | 93 | 0.32 | Why? |
| Receptors, Pattern Recognition | 2 | 2017 | 128 | 0.31 | Why? |
| Histone Deacetylase Inhibitors | 1 | 2006 | 79 | 0.31 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.31 | Why? |
| Glucocorticoids | 2 | 2017 | 4431 | 0.30 | Why? |
| Bacterial Infections | 2 | 2019 | 2229 | 0.30 | Why? |
| Toll-Like Receptor 4 | 3 | 2018 | 390 | 0.30 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.30 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.30 | Why? |
| Inflammation | 7 | 2019 | 13255 | 0.29 | Why? |
| Neutrophils | 8 | 2021 | 5476 | 0.29 | Why? |
| Immunity, Innate | 5 | 2021 | 6570 | 0.29 | Why? |
| Tobacco | 2 | 2017 | 274 | 0.29 | Why? |
| Oxidative Stress | 5 | 2019 | 2050 | 0.28 | Why? |
| Reactive Oxygen Species | 3 | 2019 | 1136 | 0.28 | Why? |
| Receptors, Glucocorticoid | 1 | 2005 | 118 | 0.27 | Why? |
| Cell Survival | 4 | 2017 | 1581 | 0.27 | Why? |
| Phenotype | 8 | 2019 | 4037 | 0.27 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.27 | Why? |
| Bronchial Hyperreactivity | 2 | 2018 | 38 | 0.26 | Why? |
| Pilot Projects | 3 | 2021 | 5182 | 0.26 | Why? |
| Cough | 1 | 2017 | 4891 | 0.26 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2002 | 32 | 0.25 | Why? |
| Fluticasone | 2 | 2017 | 65 | 0.25 | Why? |
| Cell Nucleus | 1 | 2005 | 399 | 0.24 | Why? |
| Tuberculosis | 2 | 2017 | 2895 | 0.24 | Why? |
| Anti-Inflammatory Agents | 2 | 2017 | 6153 | 0.23 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.22 | Why? |
| Interleukin-6 | 4 | 2021 | 7522 | 0.22 | Why? |
| Animals | 23 | 2020 | 78931 | 0.22 | Why? |
| Biomarkers | 15 | 2021 | 23361 | 0.21 | Why? |
| Flow Cytometry | 2 | 2020 | 2393 | 0.20 | Why? |
| Anti-Asthmatic Agents | 1 | 2005 | 427 | 0.20 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.20 | Why? |
| Humans | 65 | 2021 | 930598 | 0.20 | Why? |
| Lung Diseases | 3 | 2019 | 2361 | 0.20 | Why? |
| Receptors, Interleukin | 1 | 2019 | 83 | 0.20 | Why? |
| Iran | 3 | 2021 | 5467 | 0.20 | Why? |
| Liver Abscess | 1 | 2019 | 42 | 0.19 | Why? |
| Drug Combinations | 2 | 2021 | 3852 | 0.19 | Why? |
| NADPH Oxidases | 1 | 2019 | 80 | 0.19 | Why? |
| Poly C | 1 | 2017 | 3 | 0.18 | Why? |
| Eosinophilia | 2 | 2019 | 292 | 0.18 | Why? |
| Proteomics | 3 | 2019 | 2481 | 0.18 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 896 | 0.18 | Why? |
| Receptors, Interleukin-12 | 1 | 2017 | 14 | 0.18 | Why? |
| Bronchoalveolar Lavage Fluid | 5 | 2018 | 2309 | 0.18 | Why? |
| Oxazoles | 1 | 2018 | 75 | 0.18 | Why? |
| DNA Repair | 1 | 2018 | 114 | 0.18 | Why? |
| Bronchoconstriction | 1 | 2017 | 16 | 0.18 | Why? |
| Vasodilation | 1 | 2020 | 258 | 0.18 | Why? |
| Proteome | 2 | 2019 | 1812 | 0.18 | Why? |
| Ataxia Telangiectasia | 1 | 2017 | 12 | 0.18 | Why? |
| Paecilomyces | 1 | 2017 | 9 | 0.18 | Why? |
| Nod1 Signaling Adaptor Protein | 1 | 2017 | 23 | 0.18 | Why? |
| Gastroesophageal Reflux | 1 | 2019 | 124 | 0.18 | Why? |
| Azepines | 1 | 2017 | 17 | 0.18 | Why? |
| Tuberculosis, Pulmonary | 2 | 2019 | 1171 | 0.17 | Why? |
| Cytoskeletal Proteins | 1 | 2017 | 63 | 0.17 | Why? |
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 48 | 0.17 | Why? |
| Organic Cation Transport Proteins | 1 | 2017 | 37 | 0.17 | Why? |
| Interleukin-33 | 1 | 2018 | 120 | 0.17 | Why? |
| Enzyme Inhibitors | 2 | 2015 | 1881 | 0.17 | Why? |
| Interleukin-12 | 1 | 2018 | 156 | 0.17 | Why? |
| Immunoglobulin Light Chains | 1 | 2017 | 62 | 0.17 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.17 | Why? |
| Mitochondrial Diseases | 1 | 2017 | 62 | 0.17 | Why? |
| Acetates | 1 | 2018 | 123 | 0.17 | Why? |
| Epithelium | 1 | 2019 | 330 | 0.17 | Why? |
| Cell Proliferation | 4 | 2017 | 1973 | 0.16 | Why? |
| Nontuberculous Mycobacteria | 1 | 2018 | 114 | 0.16 | Why? |
| CpG Islands | 1 | 2018 | 230 | 0.16 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.16 | Why? |
| Lymphocytes | 3 | 2019 | 3056 | 0.16 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.16 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 198 | 0.16 | Why? |
| Interleukins | 2 | 2019 | 762 | 0.16 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 1454 | 0.16 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.16 | Why? |
| Disease | 1 | 2018 | 126 | 0.16 | Why? |
| Toll-Like Receptor 2 | 1 | 2017 | 198 | 0.16 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.16 | Why? |
| Airway Obstruction | 1 | 2018 | 182 | 0.16 | Why? |
| Lipocalin-2 | 1 | 2017 | 156 | 0.15 | Why? |
| Lung | 9 | 2019 | 31049 | 0.15 | Why? |
| Ethacrynic Acid | 1 | 2015 | 6 | 0.15 | Why? |
| Receptors, Interleukin-1 | 1 | 2017 | 161 | 0.15 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2017 | 139 | 0.15 | Why? |
| Mice | 11 | 2019 | 21357 | 0.15 | Why? |
| Cell Adhesion Molecules | 1 | 2019 | 472 | 0.15 | Why? |
| Antigens | 1 | 2017 | 267 | 0.15 | Why? |
| Systems Biology | 1 | 2018 | 320 | 0.15 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.15 | Why? |
| Female | 31 | 2021 | 380317 | 0.15 | Why? |
| Glutathione Transferase | 1 | 2015 | 86 | 0.15 | Why? |
| Male | 30 | 2021 | 367725 | 0.14 | Why? |
| Mast Cells | 1 | 2018 | 370 | 0.14 | Why? |
| Caffeic Acids | 1 | 2015 | 54 | 0.14 | Why? |
| Allografts | 1 | 2018 | 761 | 0.14 | Why? |
| Symptom Flare Up | 1 | 2018 | 432 | 0.14 | Why? |
| Epithelial Cells | 2 | 2019 | 3508 | 0.14 | Why? |
| Forced Expiratory Volume | 4 | 2019 | 632 | 0.14 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.14 | Why? |
| Macrophages, Alveolar | 1 | 2018 | 668 | 0.14 | Why? |
| Adult | 22 | 2021 | 244371 | 0.14 | Why? |
| Patient Outcome Assessment | 1 | 2018 | 707 | 0.14 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.14 | Why? |
| Cells, Cultured | 4 | 2018 | 5835 | 0.14 | Why? |
| Transcription Factor AP-1 | 1 | 2014 | 75 | 0.14 | Why? |
| Smoking | 8 | 2019 | 3358 | 0.13 | Why? |
| Interleukin-17 | 1 | 2019 | 602 | 0.13 | Why? |
| Tobacco Smoking | 1 | 2018 | 349 | 0.13 | Why? |
| Muscle, Smooth | 1 | 2014 | 67 | 0.13 | Why? |
| Biomarkers, Pharmacological | 1 | 2015 | 150 | 0.13 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2018 | 368 | 0.13 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 581 | 0.13 | Why? |
| Gene Expression | 3 | 2019 | 3332 | 0.13 | Why? |
| Furin | 1 | 2021 | 1054 | 0.13 | Why? |
| Glucose | 1 | 2018 | 573 | 0.13 | Why? |
| Receptors, Cell Surface | 1 | 2017 | 586 | 0.13 | Why? |
| Respiratory Mucosa | 2 | 2019 | 1522 | 0.13 | Why? |
| Respiration Disorders | 1 | 2019 | 526 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.12 | Why? |
| Sarcoidosis | 1 | 2017 | 271 | 0.12 | Why? |
| Case-Control Studies | 6 | 2020 | 17671 | 0.12 | Why? |
| Bronchoscopy | 2 | 2018 | 991 | 0.12 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.12 | Why? |
| Up-Regulation | 2 | 2019 | 2249 | 0.12 | Why? |
| Smokers | 1 | 2018 | 550 | 0.12 | Why? |
| Interleukin-13 | 3 | 2019 | 204 | 0.12 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.12 | Why? |
| Respiration, Artificial | 1 | 2017 | 22116 | 0.12 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.12 | Why? |
| Signal Transduction | 6 | 2019 | 7207 | 0.12 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.11 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.11 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.11 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.11 | Why? |
| Pyridines | 1 | 2017 | 680 | 0.11 | Why? |
| A549 Cells | 1 | 2017 | 2066 | 0.11 | Why? |
| Mice, Inbred C57BL | 5 | 2019 | 5542 | 0.11 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.10 | Why? |
| Cluster Analysis | 2 | 2018 | 3001 | 0.10 | Why? |
| Patient-Centered Care | 1 | 2018 | 860 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Pneumonia | 3 | 2018 | 5652 | 0.10 | Why? |
| Cell Cycle Proteins | 2 | 2017 | 297 | 0.10 | Why? |
| Desensitization, Immunologic | 1 | 2015 | 574 | 0.10 | Why? |
| Chronic Disease | 3 | 2019 | 5139 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.09 | Why? |
| Aged | 13 | 2021 | 215776 | 0.09 | Why? |
| Microbiota | 1 | 2019 | 1240 | 0.09 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Leukocyte Count | 4 | 2019 | 3178 | 0.09 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.09 | Why? |
| Bacterial Load | 2 | 2018 | 179 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.08 | Why? |
| Histone Deacetylases | 1 | 2006 | 37 | 0.08 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.08 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.08 | Why? |
| NF-kappa B | 1 | 2014 | 1301 | 0.08 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.08 | Why? |
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2005 | 1 | 0.08 | Why? |
| Protein Phosphatase 1 | 1 | 2005 | 7 | 0.08 | Why? |
| Particulate Matter | 1 | 2018 | 3249 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Phosphoprotein Phosphatases | 1 | 2005 | 8 | 0.08 | Why? |
| Protein Tyrosine Phosphatases | 1 | 2005 | 12 | 0.08 | Why? |
| Dual Specificity Phosphatase 1 | 1 | 2005 | 11 | 0.08 | Why? |
| Salmeterol Xinafoate | 1 | 2005 | 28 | 0.08 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.08 | Why? |
| Immediate-Early Proteins | 1 | 2005 | 44 | 0.07 | Why? |
| Vital Capacity | 2 | 2017 | 399 | 0.07 | Why? |
| Lung Injury | 1 | 2015 | 919 | 0.07 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.07 | Why? |
| Anthracenes | 1 | 2004 | 28 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.07 | Why? |
| Response Elements | 1 | 2005 | 54 | 0.07 | Why? |
| Proteinase Inhibitory Proteins, Secretory | 1 | 2005 | 43 | 0.07 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.07 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 59 | 0.07 | Why? |
| Beclomethasone | 1 | 2005 | 32 | 0.07 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2006 | 242 | 0.07 | Why? |
| Psoriasis | 1 | 2019 | 1739 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.07 | Why? |
| Albuterol | 1 | 2005 | 105 | 0.07 | Why? |
| Biological Transport | 1 | 2005 | 290 | 0.07 | Why? |
| Proteins | 2 | 2018 | 921 | 0.07 | Why? |
| Cell Line | 4 | 2018 | 12040 | 0.07 | Why? |
| Biological Products | 1 | 2019 | 2331 | 0.07 | Why? |
| Cytoplasm | 1 | 2005 | 304 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Transforming Growth Factor beta | 2 | 2017 | 363 | 0.06 | Why? |
| Genes, Reporter | 1 | 2005 | 472 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Luciferases | 1 | 2005 | 378 | 0.06 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2006 | 801 | 0.06 | Why? |
| Mice, Knockout | 2 | 2019 | 1815 | 0.06 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 572 | 0.06 | Why? |
| Cyclic AMP | 1 | 2002 | 76 | 0.06 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.06 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.06 | Why? |
| Skin Diseases | 1 | 2019 | 2509 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.06 | Why? |
| Phosphorylation | 2 | 2017 | 1060 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Molecular Structure | 1 | 2006 | 1539 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.05 | Why? |
| Epigenesis, Genetic | 2 | 2017 | 711 | 0.05 | Why? |
| CCN Intercellular Signaling Proteins | 1 | 2019 | 4 | 0.05 | Why? |
| Endopeptidases | 1 | 2021 | 228 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Tetradecanoylphorbol Acetate | 1 | 2018 | 23 | 0.05 | Why? |
| Rhodamines | 1 | 2018 | 19 | 0.05 | Why? |
| Transplantation Tolerance | 1 | 2018 | 13 | 0.05 | Why? |
| Airway Resistance | 1 | 2019 | 83 | 0.05 | Why? |
| Adrenal Cortex Hormones | 3 | 2018 | 6537 | 0.05 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Nasal Lavage Fluid | 1 | 2018 | 43 | 0.05 | Why? |
| RNA, Messenger | 3 | 2018 | 5131 | 0.05 | Why? |
| Caspase 1 | 1 | 2018 | 149 | 0.05 | Why? |
| Obesity | 1 | 2019 | 7388 | 0.04 | Why? |
| Mitochondrial Dynamics | 1 | 2017 | 30 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2018 | 201 | 0.04 | Why? |
| Organic Cation Transporter 2 | 1 | 2017 | 6 | 0.04 | Why? |
| Basement Membrane | 1 | 2017 | 30 | 0.04 | Why? |
| Child, Preschool | 2 | 2019 | 36283 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| Proto-Oncogene Proteins | 1 | 2019 | 340 | 0.04 | Why? |
| Wnt Signaling Pathway | 1 | 2017 | 87 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Haemophilus influenzae | 1 | 2017 | 196 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Cell Communication | 1 | 2018 | 396 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Tobacco Products | 1 | 2019 | 245 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2019 | 557 | 0.04 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.04 | Why? |
| Breath Tests | 1 | 2019 | 338 | 0.04 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.04 | Why? |
| Cell Membrane Permeability | 1 | 2015 | 84 | 0.04 | Why? |
| Drug Interactions | 1 | 2002 | 1653 | 0.04 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.04 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.04 | Why? |
| Gliotoxin | 1 | 2014 | 3 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2014 | 6 | 0.04 | Why? |
| Child | 3 | 2019 | 70012 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Spirometry | 1 | 2018 | 524 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.03 | Why? |
| Thiocarbamates | 1 | 2014 | 31 | 0.03 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 28 | 0.03 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.03 | Why? |
| Retinoids | 1 | 2014 | 43 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.03 | Why? |
| fas Receptor | 1 | 2014 | 85 | 0.03 | Why? |
| I-kappa B Kinase | 1 | 2014 | 98 | 0.03 | Why? |
| Quinoxalines | 1 | 2014 | 95 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.03 | Why? |
| Glutathione | 1 | 2015 | 280 | 0.03 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Immunoenzyme Techniques | 1 | 2015 | 448 | 0.03 | Why? |
| Blotting, Western | 1 | 2015 | 863 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.03 | Why? |
| Primary Cell Culture | 1 | 2014 | 501 | 0.03 | Why? |
| Picornaviridae Infections | 1 | 2018 | 544 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.03 | Why? |
| Inflammasomes | 1 | 2018 | 710 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.03 | Why? |
| Mice, Inbred BALB C | 2 | 2017 | 5814 | 0.03 | Why? |
| Intersectoral Collaboration | 1 | 2018 | 1065 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.03 | Why? |
| Drug Therapy, Combination | 1 | 2005 | 7268 | 0.03 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.03 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2015 | 817 | 0.03 | Why? |
| Pyrrolidines | 1 | 2014 | 558 | 0.02 | Why? |
| Hydrogen Peroxide | 1 | 2015 | 680 | 0.02 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2019 | 1579 | 0.02 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.02 | Why? |
| Metabolomics | 1 | 2015 | 921 | 0.02 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.02 | Why? |
| Imidazoles | 1 | 2014 | 631 | 0.02 | Why? |
| Netherlands | 1 | 2017 | 3533 | 0.02 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2019 | 1545 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Immunity | 1 | 2019 | 2651 | 0.02 | Why? |
| Antibodies | 1 | 2014 | 846 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 11367 | 0.02 | Why? |
| Antioxidants | 1 | 2015 | 1593 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Protein Domains | 1 | 2017 | 6563 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.02 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Virus Shedding | 1 | 2017 | 5834 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2017 | 53120 | 0.01 | Why? |
| Protein Binding | 1 | 2014 | 11430 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 13720 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |